<DOC>
	<DOC>NCT00998933</DOC>
	<brief_summary>To further characterize the transfer potential of marketed testosterone gel and new 1.62% formulation.</brief_summary>
	<brief_title>Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Healthy male and female volunteers, with a BMI 2035 kg/m2 (males) and 2030 kg/m2 (females). Males: history, current or suspected prostate or breast cancer. Female: pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Testosterone replacement therapy</keyword>
</DOC>